Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues

• Autori principali: Monica Verdoia (Autore), Cyril Camaro (Autore), Elvin Kedhi (Autore), Marco Marcolongo (Autore), Harry Suryapranata (Autore), Giuseppe De Luca (Autore)
• Natura: Libro
• Pubblicazione: Hindawi-Wiley, 2020-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Conflicting results have been reported so far in pooled analyses and studies evaluating the optimum duration of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) patients. However, randomized clinical trials dedicated to this specific setting of higher thrombotic risk patients have o...